Literature DB >> 25617807

Risk Factors for Steroid-Refractory Acute Graft-versus-Host Disease after Allogeneic Stem Cell Transplantation from Matched Related or Unrelated Donors.

Claire Calmettes1, Stéphane Vigouroux2, Myriam Labopin3, Reza Tabrizi1, Pascal Turlure4, Xavier Lafarge5, Gérald Marit6, Arnaud Pigneux6, Thibaut Leguay1, Krimo Bouabdallah1, Marie-Sarah Dilhuydy1, Cédric Duclos1, Catherine Mohr1, Axelle Lascaux1, Pierre-Yves Dumas1, Sophie Dimicoli-Salazar1, Arnaud Saint-Lézer1, Noël Milpied6.   

Abstract

We performed a retrospective study to identify pretransplantation risk factors for steroid-refractory (SR) acute graft-versus host disease (aGVHD) after allogeneic stem cell transplantation from matched donors in 630 adult patients who underwent transplantation at our center between 2000 and 2012. The cumulative incidence (CI) of SR aGVHD was 11.3% ± 2.3%. The identified independent risk factors were matched unrelated donor (hazard ratio [HR], 2.52; P = .001), female donor for male recipient (HR, 1.84; P = .023) and absence of antithymocyte globulin (HR, 2.02; P = .005). Three risk groups were defined according to the presence of these risk factors. In the whole cohort, the CI of SR aGVHD was 3.5% ± 1.7% in the low-risk group (0 risk factor, n = 115), 9.3% ± 1.6% in the intermediate-risk group (1 risk factor, n = 323), and 19.3% ± 2.9% in the high-risk group (2 or 3 risk factors, n = 192). Our study suggests that pretransplantation characteristics might help identify patients at high risk for SR aGVHD. A risk adapted first-line treatment of aGVHD could be evaluated in those patients.
Copyright © 2015 American Society for Blood and Marrow Transplantation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Risk factors; Steroid-refractory acute graft-versus-host disease

Mesh:

Year:  2015        PMID: 25617807     DOI: 10.1016/j.bbmt.2015.01.016

Source DB:  PubMed          Journal:  Biol Blood Marrow Transplant        ISSN: 1083-8791            Impact factor:   5.742


  7 in total

1.  Alpha-1 Antitrypsin-Expressing Mesenchymal Stromal Cells Confer a Long-Term Survival Benefit in a Mouse Model of Lethal GvHD.

Authors:  Sabine Geiger; Emrah I Ozay; Ulf Geumann; Marina K Hereth; Terese Magnusson; Sudarvili Shanthalingam; Daniela Hirsch; Stefanie Kälin; Christine Günther; Barbara A Osborne; Gregory N Tew; Felix G Hermann; Lisa M Minter
Journal:  Mol Ther       Date:  2019-05-16       Impact factor: 11.454

2.  Phase I/II Trial of a Combination of Anti-CD3/CD7 Immunotoxins for Steroid-Refractory Acute Graft-versus-Host Disease.

Authors:  Christoph Groth; Lenneke F J van Groningen; Tiago R Matos; Manita E Bremmers; Frank W M B Preijers; Harry Dolstra; Christian Reicherts; Nicolaas P M Schaap; Eric H G van Hooren; Joanna IntHout; Rosalinde Masereeuw; Mihai G Netea; John E Levine; George Morales; James L Ferrara; Nicole M A Blijlevens; Ypke V J M van Oosterhout; Matthias Stelljes; Walter J F M van der Velden
Journal:  Biol Blood Marrow Transplant       Date:  2018-11-03       Impact factor: 5.742

Review 3.  Angiogenic factors and inflammation in steroid-refractory acute graft-vs-host disease.

Authors:  Shernan G Holtan; Mukta Arora
Journal:  Transl Res       Date:  2015-06-09       Impact factor: 7.012

Review 4.  A fludarabine and melphalan reduced-intensity conditioning regimen for HSCT in fifteen chronic granulomatous disease patients and a literature review.

Authors:  Mohammad Vaezi; Maryam Souri; Seyed Amin Setarehdan; Amir Ali Hamidieh; Mohammad Reza Fazlollahi; Zahra Pourpak; Mohsen Badalzadeh; Shaghayegh Tajik; Seyed Alireza Mahdaviani; Kamran Alimoghaddam; Ardeshir Ghavamzadeh
Journal:  Ann Hematol       Date:  2022-01-08       Impact factor: 3.673

5.  HLA-C KIR-Ligands Determine the Impact of Anti-Thymocyte Globulin (ATG) on Graft versus Host and Graft versus Leukemia Effects Following Hematopoietic Stem Cell Transplantation.

Authors:  Johannes Clausen; Alexandra Böhm; Irene Straßl; Olga Stiefel; Veronika Buxhofer-Ausch; Sigrid Machherndl-Spandl; Josef König; Stefan Schmidt; Hansjörg Steitzer; Martin Danzer; Hedwig Kasparu; Ansgar Weltermann; David Nachbaur
Journal:  Biomedicines       Date:  2017-03-28

6.  Similar Outcomes in Early-Failure Steroid-Dependent Compared to Upfront Steroid Refractory Acute Graft-Versus-Host Disease Following Allogeneic Hematopoietic Cell Transplant.

Authors:  Dilan A Patel; Karina A Mendoza; Heidi Chen; Brian G Engelhardt; Bipin N Savani; Stacey A Goodman; Jeremy Warner; Adetola A Kassim; Michael Byrne; Wichai Chinratanalab; John P Greer; Carole Hunt; Madan Jagasia
Journal:  J Hematol       Date:  2021-02-06

Review 7.  Steroid-Refractory Gut Graft-Versus-Host Disease: What We Have Learned From Basic Immunology and Experimental Mouse Model.

Authors:  Qingxiao Song; Ubaydah Nasri; Defu Zeng
Journal:  Front Immunol       Date:  2022-02-18       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.